Eviprostat


Indications and Reactions:

Role Indications Reactions
Secondary
Benign Prostatic Hyperplasia 34.6%
Constipation 11.1%
Parkinson's Disease 9.9%
Hypertension 6.2%
Product Used For Unknown Indication 3.7%
Bronchitis Chronic 2.5%
Chronic Myeloid Leukaemia 2.5%
Chronic Obstructive Pulmonary Disease 2.5%
Dementia With Lewy Bodies 2.5%
Diabetic Retinal Oedema 2.5%
Folliculitis 2.5%
Gastric Ulcer 2.5%
Haemorrhoids 2.5%
Headache 2.5%
Hyperlipidaemia 2.5%
Hypotension 2.5%
Neurogenic Bladder 2.5%
Pyrexia 2.5%
Computerised Tomogram 1.2%
Dermatitis 1.2%
Medication Error 25.0%
Prostate Cancer 15.0%
Urinary Retention 15.0%
Sleep Disorder 10.0%
Dysarthria 5.0%
Hepatitis Viral 5.0%
Liver Disorder 5.0%
Platelet Count Decreased 5.0%
Second Primary Malignancy 5.0%
Thrombocytopenia 5.0%
Tuberculous Pleurisy 5.0%
Concomitant
Benign Prostatic Hyperplasia 24.5%
Hypertension 10.5%
Drug Use For Unknown Indication 7.2%
Cerebral Infarction 5.9%
Product Used For Unknown Indication 5.6%
Hyperlipidaemia 5.5%
Hyperuricaemia 5.4%
Metastatic Renal Cell Carcinoma 3.9%
Prostate Cancer 3.4%
Renal Cell Carcinoma 3.4%
Insomnia 3.2%
Parkinson's Disease 3.0%
Constipation 2.9%
Chronic Obstructive Pulmonary Disease 2.6%
Colorectal Cancer 2.6%
Rheumatoid Arthritis 2.6%
Prophylaxis 2.2%
Hypopharyngeal Cancer 1.9%
Gastritis 1.8%
Hypertonic Bladder 1.8%
Interstitial Lung Disease 12.2%
Rhabdomyolysis 10.6%
Pyrexia 9.8%
Death 6.5%
Tracheal Haemorrhage 6.5%
Tuberculosis 5.7%
Vomiting 5.7%
Hepatic Function Abnormal 4.9%
White Blood Cell Count Decreased 4.9%
Hyponatraemia 3.3%
Myocardial Infarction 3.3%
Neutropenia 3.3%
Pneumonia 3.3%
Respiratory Failure 3.3%
Sepsis 3.3%
Stomatitis 3.3%
Urinary Retention 3.3%
Alanine Aminotransferase Increased 2.4%
Amnesia 2.4%
Aortic Dissection 2.4%

Drug Data